Overexpression of PAD4 Suppresses Drug Resistance of NSCLC Cell Lines to Gefitinib Through Inhibiting Elk1-Mediated Epithelial-Mesenchymal Transition
Oncology Reports - Greece
doi 10.3892/or.2016.4780
Full Text
Open PDFAbstract
Available in full text
Date
April 28, 2016
Authors
Publisher
Spandidos Publications